RALLYBIO CORPORATION Increase (Decrease) in Accounts Payable
RALLYBIO CORPORATION (RLYB) reported Increase (Decrease) in Accounts Payable of $707.00 thousand for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-08-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-26
- RALLYBIO CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$107.00K.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $814.00K, a 567.21% increase year-over-year.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$143.00K.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $150.00K.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for fiscal 2023 was -$99.00K, a 120.33% decline from fiscal 2022.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for fiscal 2022 was $487.00K.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for fiscal 2021 was -$976.00K, a 234.99% decline from fiscal 2020.
- RALLYBIO CORPORATION increase (decrease) in accounts payable for fiscal 2020 was $723.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$107.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-08-26 | $707.00K S-4/A · filed 2026-08-26 | $564.00K derived: sum of 3 quarters · filed 2026-08-26 | $714.00K derived: sum of 4 quarters · filed 2026-08-26 |
| 2026-03-31 | $814.00K S-4 · filed 2026-07-15 | $671.00K derived: sum of 2 quarters · filed 2026-08-26 | $821.00K derived: sum of 3 quarters · filed 2026-08-26 | $540.00K derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-12-31 | -$143.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-08-26 | $7.00K derived: sum of 2 quarters · filed 2026-08-26 | -$274.00K derived: sum of 3 quarters · filed 2026-08-26 | -$152.00K S-4/A · filed 2026-08-26 |
| 2025-09-30 | $150.00K derived: 10-Q 9 month − S-4/A 6 month · filed 2025-11-06 | -$131.00K derived: sum of 2 quarters · filed 2026-08-26 | -$9.00K 10-Q · filed 2025-11-06 | -$314.00K derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-06-30 | -$281.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-08-26 | -$159.00K S-4/A · filed 2026-08-26 | -$464.00K derived: sum of 3 quarters · filed 2026-08-26 | -$1.10M derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-03-31 | $122.00K S-4 · filed 2026-07-15 | -$183.00K derived: sum of 2 quarters · filed 2026-08-26 | -$818.00K derived: sum of 3 quarters · filed 2026-08-26 | -$70.00K derived: sum of 4 quarters · filed 2026-08-26 |
| 2024-12-31 | -$305.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-08-26 | -$940.00K derived: sum of 2 quarters · filed 2026-08-26 | -$192.00K derived: sum of 3 quarters · filed 2026-08-26 | -$698.00K S-4/A · filed 2026-08-26 |
| 2024-09-30 | -$635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $113.00K derived: sum of 2 quarters · filed 2025-11-06 | -$393.00K 10-Q · filed 2025-11-06 | $131.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $748.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $242.00K 10-Q · filed 2025-08-07 | $766.00K derived: sum of 3 quarters · filed 2025-08-07 | $530.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$506.00K 10-Q · filed 2025-05-08 | $18.00K derived: sum of 2 quarters · filed 2025-05-08 | -$218.00K derived: sum of 3 quarters · filed 2025-05-08 | -$310.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $288.00K derived: sum of 2 quarters · filed 2025-03-13 | $196.00K derived: sum of 3 quarters · filed 2025-03-13 | -$99.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | -$236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$328.00K derived: sum of 2 quarters · filed 2024-11-07 | -$623.00K 10-Q · filed 2024-11-07 | -$231.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$387.00K 10-Q · filed 2024-08-08 | $5.00K derived: sum of 3 quarters · filed 2024-08-08 | $77.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$295.00K 10-Q · filed 2024-05-09 | $97.00K derived: sum of 2 quarters · filed 2024-05-09 | $169.00K derived: sum of 3 quarters · filed 2024-05-09 | -$255.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $464.00K derived: sum of 2 quarters · filed 2024-03-12 | $40.00K derived: sum of 3 quarters · filed 2024-03-12 | $487.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$352.00K derived: sum of 2 quarters · filed 2023-11-09 | $95.00K 10-Q · filed 2023-11-09 | -$274.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $23.00K 10-Q · filed 2023-08-08 | -$346.00K derived: sum of 3 quarters · filed 2023-08-08 | -$1.74M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $447.00K 10-Q · filed 2023-05-09 | $78.00K derived: sum of 2 quarters · filed 2023-05-09 | -$1.32M derived: sum of 3 quarters · filed 2023-05-09 | -$1.96M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$1.76M derived: sum of 2 quarters · filed 2023-03-06 | -$2.41M derived: sum of 3 quarters · filed 2023-03-06 | -$976.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$2.04M derived: sum of 2 quarters · filed 2022-11-07 | -$607.00K 10-Q · filed 2022-11-07 | $225.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $787.00K 10-Q · filed 2022-08-08 | $1.62M derived: sum of 3 quarters · filed 2022-08-08 | $1.96M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $1.43M 10-Q · filed 2022-05-10 | $2.26M derived: sum of 2 quarters · filed 2022-05-10 | $2.60M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $832.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.17M derived: sum of 2 quarters · filed 2022-03-15 | $723.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$109.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$449.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |